JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36B
| $12.2M | ﹤0.01% |
312,493
+279,419
| +845% | +$10.7M |
2019 Q4
12 quarters
|
|
2002
Gogo Inc
GOGO
$290M
| $12.1M | ﹤0.01% |
822,524
+192,810
| +31% | +$2.78M |
2016 Q3
25 quarters
|
|
2003
Vaxcyte
PCVX
$11B
| $12.1M | ﹤0.01% |
252,932
+72,805
| +40% | +$2.86M |
2020 Q3
9 quarters
|
|
2004
PUT
Aflac
AFL
$56.3B
| $12.1M | ﹤0.01% |
168,500
+77,800
| +86% | +$5.21M |
2022 Q3
1 quarter
|
|
2005
Trustmark
TRMK
$2.64B
| $12.1M | ﹤0.01% |
347,238
-79,505
| -19% | -$2.78M |
2013 Q2
38 quarters
|
|
|
ZING
2006
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $12.1M | ﹤0.01% |
1,199,500
+939,500
| +361% | +$9.43M |
2022 Q1
3 quarters
|
|
2007
JetBlue
JBLU
$1.53B
| $12.1M | ﹤0.01% |
1,868,994
+864,437
| +86% | +$6.32M |
2014 Q3
33 quarters
|
|
|
SPTN
2008
DELISTED
SpartanNash
SPTN
| $12.1M | ﹤0.01% |
400,459
-340,643
| -46% | -$11.1M |
2013 Q2
38 quarters
|
|
2009
Ryder
R
$9.05B
| $12.1M | ﹤0.01% |
144,839
-24,462
| -14% | -$2.05M |
2013 Q2
38 quarters
|
|
2010
Jacobs Solutions
J
$16.2B
| $12.1M | ﹤0.01% |
121,847
-30,865
| -20% | -$3.03M |
2013 Q2
38 quarters
|
|
2011
Preferred Bank
PFBC
$1.25B
| $12.1M | ﹤0.01% |
162,120
-2,410
| -1% | -$176K |
2013 Q2
38 quarters
|
|
2012
FTI Consulting
FCN
$3.81B
| $12.1M | ﹤0.01% |
76,032
-12,579
| -14% | -$2.1M |
2013 Q2
38 quarters
|
|
2013
Independent Bank Corp
IBCP
$797M
| $12.1M | ﹤0.01% |
504,698
+7,254
| +1% | +$165K |
2015 Q3
29 quarters
|
|
2014
Haemonetics
HAE
$4.76B
| $12M | ﹤0.01% |
153,205
+6,752
| +5% | +$543K |
2015 Q4
28 quarters
|
|
2015
Mattel
MAT
$4.59B
| $12M | ﹤0.01% |
673,582
-19,500
| -3% | -$354K |
2013 Q2
38 quarters
|
|
2016
PJT Partners
PJT
$3.53B
| $12M | ﹤0.01% |
162,685
-17,321
| -10% | -$1.3M |
2015 Q4
28 quarters
|
|
2017
CALL
Southern Company
SO
$96.4B
| $12M | ﹤0.01% |
167,500
+96,000
| +134% | +$6.42M |
2021 Q2
6 quarters
|
|
2018
iShares MSCI ACWI ex US ETF
ACWX
$17.7B
| $11.9M | ﹤0.01% |
262,237
+64,086
| +32% | +$2.81M |
2013 Q2
38 quarters
|
|
2019
Cathay General Bancorp
CATY
$4.03B
| $11.9M | ﹤0.01% |
292,356
-158,474
| -35% | -$6.86M |
2013 Q2
38 quarters
|
|
|
SGI
2020
Somnigroup International
SGI
$14.3B
| $11.9M | ﹤0.01% |
346,346
-13,519
| -4% | -$407K |
2013 Q2
38 quarters
|
|
2021
Arcos Dorados Holdings
ARCO
$1.71B
| $11.9M | ﹤0.01% |
1,421,152
-140,621
| -9% | -$1.05M |
2019 Q3
13 quarters
|
|
2022
Sociedad Química y Minera de Chile
SQM
$18.8B
| $11.8M | ﹤0.01% |
148,410
-114,656
| -44% | -$10.6M |
2014 Q1
35 quarters
|
|
2023
VanEck Biotech ETF
BBH
$480M
| $11.8M | ﹤0.01% |
74,143
-1,436
| -2% | -$227K |
2022 Q2
2 quarters
|
|
2024
Maximus
MMS
$2.85B
| $11.8M | ﹤0.01% |
161,455
+2,844
| +2% | +$184K |
2013 Q2
38 quarters
|
|
2025
Synaptics
SYNA
$4.75B
| $11.8M | ﹤0.01% |
124,429
+10,318
| +9% | +$992K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.